Benefits of VILPA in Young Adults
- Conditions
- Activity, MotorHealth Behavior
- Registration Number
- NCT06259370
- Lead Sponsor
- Xiao-dong Zhuang
- Brief Summary
The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population.
The main question it aims to answer is:
\[1\] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Healthy Adults
- No exercise habits (more than 3 months)
- Exercising ≥ 3 times per week;
- the presence of chronic diseases, such as hypertension, hyperglycemic states, etc;
- have conducted an exercise program in the past three months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Isokinetic strength testing 30 minutes Isokinetic strength testing with the Isomed 2000
Surface electromyography 15 minutes a standard surface electromyography system (MyoMove-EOW, NCC, China) was utilized. Surface electrodes were placed using the belly tendon method at 6 specified locations on both sides of the lower legs (anterior tibialis on both sides, gastrocnemius on both sides, and soleus on both sides). The electrode placement positions and operational procedures strictly adhered to the SENIAM guidelines (http://www.seniam.org). During the testing process, root mean square (RMS) and averaged electromyography (AEMG) values were collected to reflect the muscle force and motor unit recruitment of the selected muscle groups.
- Secondary Outcome Measures
Name Time Method Blood lipid 5 minutes encompassing high-density lipoprotein cholesterol (HDL-C) and triglycerides, were assessed using the CardioChek device (Polymer Technology Systems, Inc., 7736 Zionsville Road, USA)
Trial Locations
- Locations (1)
Guangdong Pharmaceutical University
🇨🇳Guangzhou, Guangdong, China
Guangdong Pharmaceutical University🇨🇳Guangzhou, Guangdong, China